Biogen Idec, Inc. (BIIB) Tops Q2 EPS by 37c; Issues Solid Guidance
Tweet Send to a Friend
Biogen Idec, Inc. (NASDAQ: BIIB) reported Q2 EPS of $2.30, $0.37 better than the analyst estimate of $1.93. Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE